Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Total Current Liabilities (2016 - 2025)

AtriCure (ATRC) has disclosed Total Current Liabilities for 16 consecutive years, with $81.5 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 11.03% to $81.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $81.5 million through Dec 2025, up 11.03% year-over-year, with the annual reading at $81.5 million for FY2025, 11.03% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $81.5 million at AtriCure, up from $77.8 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $82.5 million in Q3 2023, with the low at $47.4 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $65.3 million, with a median of $61.9 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities skyrocketed 77.21% in 2021, then decreased 18.97% in 2022.
  • Over 5 years, Total Current Liabilities stood at $56.4 million in 2021, then grew by 3.45% to $58.4 million in 2022, then grew by 27.7% to $74.6 million in 2023, then fell by 1.54% to $73.4 million in 2024, then increased by 11.03% to $81.5 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $81.5 million, $77.8 million, and $68.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.